Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Express Scripts
Baxter
Covington
UBS
Daiichi Sankyo
Cerilliant
QuintilesIMS
Argus Health
Dow

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062325

« Back to Dashboard

NDA 062325 describes GENTAMICIN, which is a drug marketed by Intl Medication, Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs Inc, Perrigo New York, Pharmaderm, Taro, Abbott, Fresenius Kabi Usa, Hospira, Kalapharm, Pharm Spec, Solopak, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Akorn, Perrigo Co Tennessee, Alcon Pharms Ltd, Bausch And Lomb, Paco, Sandoz Inc, B Braun, and Baxter Hlthcare, and is included in thirty-eight NDAs. Additional details are available on the GENTAMICIN profile page.

The generic ingredient in GENTAMICIN is gentamicin sulfate. There are fifteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
Summary for 062325
Tradename:GENTAMICIN
Applicant:Intl Medication
Ingredient:gentamicin sulfate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 40MG BASE/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 1MG BASE/ML
Approval Date:Jun 23, 1982TE:RLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 100MG BASE/100ML
Approval Date:Jun 23, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Moodys
QuintilesIMS
Fish and Richardson
Cantor Fitzgerald
Queensland Health
Chubb
Baxter
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot